High real-world effectiveness of elbasvir/grazoprevir in PWID on opioid substitution therapy with HCV genotype 1 infection: Results from the German hepatitis C registry (DHC-R)

被引：0

作者：

Christensen, Stefan ^{[1
]}

Stoehr, Albrecht ^{[2
]}

Cornberg, Markus ^{[3
]}

Klinker, Hartwig ^{[4
]}

Heyne, Renate ^{[5
]}

John, Christine

Simon, Karl-Georg ^{[6
]}

Bilzer, Manfred ^{[7
]}

Guenther, Veronika ^{[8
]}

Witte, Vanessa ^{[8
]}

Reimer, Jens ^{[9
,10
]}

机构：

[1] CIM Muenster, Munster, Germany

[2] Study Ctr St Georg, Ifi Inst Interdisciplinary Med, Hamburg, Germany

[3] Hannover Med Sch, Hannover, Germany

[4] Univ Hosp Wuerzburg, Wurzburg, Germany

[5] Leberzentrum Checkpoint, Berlin, Germany

[6] Schwarz GbR, MVZ Dres Eisenbach, Leverkusen, Germany

[7] Bilzer Consulting, Munich, Germany

[8] MSD Sharp & Dohme GmbH, Haar, Germany

[9] Univ Hosp Hamburg, Hamburg, Germany

[10] Hlth North Hosp Grp Bremen, Bremen, Germany

来源：

JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期

关键词：

D O I：

10.1016/S0618-8278(19)30400-1

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU-125

引用

页码：E214 / E214

页数：1

共 50 条

[31] Effectiveness and safety of elbasvir grazoprevir in Korean patients with hepatitis C virus infection: a nationwide real-world study
Jang, Eun Sun
Kim, Kyung-Ah
Kim, Young Seok
Kim, In Hee
Lee, Byung Seok
Lee, Youn Jae
Chung, Woo Jin
Jeong, Sook-Hyang
KOREAN JOURNAL OF INTERNAL MEDICINE, 2021, 36 : S1 - U328
[32] DAA-Treatment of HCV-infected patients on Opioid Substitution Therapy (OST): does the clinical setting matter? Data from the German Hepatitis C-Registry (DHC-R)
Christensen, Stefan
Schober, Andreas
Mauss, Stefan
Busch, Heiner W.
Guenther, Rainer
Teuber, Gerlinde
Buggisch, Peter
Pfeiffer-Vornkahl, Heike
Weber, Bernd
Reimer, Jens
Weckbecker, Klaus
Wedemeyer, Heiner
HEPATOLOGY, 2016, 64 : 982A - 983A
[33] Inadvertent "off label" DAA treatment in the real-world and importance for virologic outcome - data from the German hepatitis C-Registry (DHC-R)
Buggisch, Peter
Schmitt, Annika
Mauss, Stefan
Boeker, Klaus
Klinker, Hartwig
Stoehr, Albrecht
Heyne, Renate
Cornberg, Markus
Sarrazin, Christoph
JOURNAL OF HEPATOLOGY, 2020, 73 : S335 - S335
[34] Treatment-failure to direct antiviral regimens in real world: frequency, patient characteristics and rescue therapy - Results from the German Hepatitis C-Registry (DHC-R)
Sarrazin, Christoph
Boeker, Klaus H.
Mauss, Stefan
Guenther, Rainer
Buggisch, Peter
Goeser, Tobias
Pathil, Anita
Niederau, Claus
Vermehren, Johannes
Wedemeyer, Heiner
HEPATOLOGY, 2017, 66 : 849A - 849A
[35] PROGNOSTIC IMPACT OF STEATOSIS IN THE NATURAL COURSE OF PATIENTS WITH CHRONIC HEPATITIS C INFECTION - RESULTS FROM THE GERMAN HEPATITIS C-REGISTRY (DHC-R)
Rau, Monika
Buggisch, Peter
Mauss, Stefan
Boeker, Klaus H. W.
Klinker, Hartwig
Mueller, Tobias
Stoehr, Albrecht
Schattenberg, Joern
Geier, Andreas
HEPATOLOGY, 2019, 70 : 325A - 325A
[36] Variables associated with treatment outcomes for hepatitis C genotype 1 infection with direct acting antivirals (DAA): Data from the German Hepatitis C-Registry (DHC-R)
Mauss, Stefan
Buggisch, Peter
Boeker, Klaus H.
Schott, Eckart
Klinker, Hartwig H.
Guenther, Rainer
Pfeiffer-Vornkahl, Heike
Berg, Thomas
Sarrazin, Christoph
Hueppe, Dietrich
Manns, Michael P.
HEPATOLOGY, 2016, 64 : 438A - 438A
[37] Improvement of Clinical Symptoms and Patient-Reported Outcomes (PRO) after HCV Therapy with Daa in Patients on Opioid Substitution Therapy (OST) - DATA from the German Hepatitis C-Registry (DHC-R)
Christensen, Stefan
Naumann, Uwe
Link, Ralph
Heyne, Renate
Nowak, Manfred
Guenther, Rainer
Buggisch, Peter
Schaefer, Arne
Kraus, Michael R.
Mauss, Stefan
Cornberg, Markus
Serfert, Yvonne
Wedemeyer, Heiner
HEPATOLOGY, 2018, 68 : 393A - 393A
[38] EFFECTIVENESS OF SOFOSBUVIR/VELPATASVIR AND ELBASVIR/GRAZOPREVIR FOR THE TREATMENT OF HCV GENOTYPE 1 INFECTION IN A REAL-WORLD COHORT WITH NUMEROUS PEOPLE WHO USE DRUGS (PWUD)
Wuerth, Kelli
Magel, Tianna
Thiam, Astou
Alimohammadi, Arshia
Yung, Rossitta
Truong, David
Conway, Brian
HEPATOLOGY, 2019, 70 : 959A - 959A
[39] Dynamics of Liver Stiffness By Transient Elastography in Patients with Chronic Hepatitis C (HCV) Infection Receiving Direct Acting Antiviral Therapy-Results from the German Hepatitis C-Registry (DHC-R)
Knop, Viola
Mauss, Stefan
Goeser, Tobias
Geier, Andreas
Zimmermann, Tim
Herzer, Kerstin
Postel, Nils
Hofmann, Wolf Peter
HEPATOLOGY, 2018, 68 : 424A - 424A
[40] Frequency and predictive value of detectable HCV RNA at the end of treatment with ledipasvir/sofosbuvir ± ribavirin in a large real world cohort: Results from the German Hepatitis C-Registry (DHC-R)
Maasoumy, Benjamin
Mauss, Stefan
Buggisch, Peter
Boeker, Klaus H.
Gunther, Rainer
Manns, Michael P.
Pfeiffer-Vornkahl, Heike
Klinker, Hartwig H.
Schott, Eckart
Sarrazin, Christoph
Wedemeyer, Heiner
Hueppe, Dietrich
Vermehren, Johannes
HEPATOLOGY, 2016, 64 : 480A - 481A

← 1 2 3 4 5 →